CWPWF yields 11.16% · PFE yields 6.13%● Live data
📍 CWPWF pulled ahead of the other in Year 1
Combined, CWPWF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWPWF + PFE for your $10,000?
Concord New Energy Group Limited, an investment holding company, engages in the generation of power in the People's Republic of China and internationally. The company operates through Power Generation, Intelligent Operation and Maintenance, and Others segments. It is involved in the investment, engineering, procurement, construction, operation, and maintenance of wind and solar power plants; and provision of design, technical, and consultancy services. The company also engages in the sale of solar and new energy equipment; design, research, and exploitation of power systems; leasing of equipment; and investment and operation of solar and wind power plants. In addition, it provides finance lease services and energy internet services. The company sells its electric power to external power grid companies. As of December 31, 2021, it had 70 grid-connected wind and photovoltaic power plants with a total installed capacity of approximately 3,708 megawatts, which include 54 wind power plants with an installed capacity of 3,313 megawatts, as well as 16 photovoltaic power plants with an installed capacity of 394 megawatts. The company was formerly known as China Windpower Group Limited and changed its name to Concord New Energy Group Limited in March 2015. The company was founded in 2006 and is based in Admiralty, Hong Kong.
Full CWPWF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.